Prognostic Significance of FDG PET/CT on the Follow-Up of Patients of Differentiated Thyroid Carcinoma With Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels

2012 ◽  
Vol 37 (10) ◽  
pp. 953-959 ◽  
Author(s):  
Gulin Ucmak Vural ◽  
Burcu Esen Akkas ◽  
Nur Ercakmak ◽  
Sandip Basu ◽  
Abass Alavi
2009 ◽  
Vol 30 (8) ◽  
pp. 639-650 ◽  
Author(s):  
Meng-Jie Dong ◽  
Zhen-Feng Liu ◽  
Kui Zhao ◽  
Ling-Xiang Ruan ◽  
Guo-Lin Wang ◽  
...  

2014 ◽  
Vol 53 (18) ◽  
pp. 2095-2099 ◽  
Author(s):  
Hae Jung Na ◽  
Bo Hyun Kim ◽  
Ji Ryang Kim ◽  
Min Young Oh ◽  
Sang Mi Kim ◽  
...  

2008 ◽  
Vol 33 (12) ◽  
pp. 882-886
Author(s):  
Piergiuseppe Orsolon ◽  
Marcello Giachetti ◽  
Andrea Lupi ◽  
Matteo Salgarello ◽  
Veronica Malfatti ◽  
...  

2009 ◽  
Vol 53 (7) ◽  
pp. 874-879 ◽  
Author(s):  
Maria Eduarda Mello ◽  
Rodrigo C. Flamini ◽  
Rossana Corbo ◽  
Marcelo Mamede

The radioactive iodine has been used with great value as a diagnostic and therapeutic method in patients with differentiated thyroid carcinoma previously submitted to total thyroidectomy. False-positive whole-body scans may occur due to misinterpretation of the physiologic distribution of the radioisotope or lack of knowledge on the existence of other pathologies that could eventually present radioiodine uptake. Thymic uptake is an uncommon cause of false-positive whole-body scan, and the mechanism through which it occurs is not completely understood. The present paper reports five cases of patients with differentiated thyroid cancer who presented a mediastinum uptake of radioiodine in a whole-body scan during follow-up. The patients had either histological or radiological confirmation of the presence of residual thymus gland. It is very important to know about the possibility of iodine uptake by the thymus in order to avoid unnecessary treatment, such as surgery or radioiodine therapy.


Sign in / Sign up

Export Citation Format

Share Document